FUJI PHARMACEUTICAL CO LTD
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Full year to Full year ended
Mar 31, 2009 Mar 31, 2008 Sep 30, 2009 Sep 30, 2008
LATEST YEAR-AGO COMPANY YEAR-AGO
H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 7.58 6.84 17.00
(+6.7 pct) (+13.8%)
Operating 943 mln 1.03 2.30
(-2.5 pct) (+11.3%)
Recurring 952 mln 1.03 2.31
(-2.7 pct) (+10.7%)
Net 547 mln 639 mln 1.36
(+7.4 pct) (+8.7%)
EPS Y42.51 Y49.66 Y105.67
Shares 13 mln 13 mln -Q2 div Y11.00 Y10.00
Annual div Y23.00 Y20.0
0 -Q4 div Y10.00 Y12.00
NOTE - Fuji Pharmaceutical Co Ltd focuses on hormone preparations, antibotics and circulatory drugs.
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed companies to pay and report dividends on a quarterly basis.
No comments:
Post a Comment